All subordinate units of the group commend advanced
Release time:
2021-02-10
1# On May 25, at the 2020 work summary meeting held by Yunnan Jianfeng Cement Company, Zhou Jiping made a work report on behalf of Yunnan Jianfeng management team to summarize the production and operation situation in 2020. In 2020, Yunnan Peak overcame the impact of the epidemic and regional new capacity, in the difficult market environment, bucked the trend to create the highest sales in the eight years since the establishment of the plant, to achieve the only sales in southwest Yunnan over last year, the only receivables cleared of the same industry enterprises. Zhou Jiping objectively analyzed the problems and deficiencies in the work, and combined with the actual work in 2020, put forward suggestions on the business objectives, key work plans, work requirements and safeguard measures for 2021. Liu Shenghua, the new general manager of Yunnan Peak, has arranged the work for 2021 in combination with the actual production of Yunnan Peak. The
meeting commended the advanced collectives and individuals in 2020. Fang Xuhua, secretary of the Yunnan Jianfeng Party Branch, deputy general manager, and chairman of the labor union, hopes that all cadres and employees will take the advanced as an example and benchmark, find gaps based on their positions, everyone talks about performance than dedication, and is in line with the advanced, and in the face of new production and operation tasks, Strive to catch up and surpass head-on and reach a new high. At the summary and commendation meeting of the pharmaceutical company held on October 3, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, made an annual work report on behalf of the management team of the pharmaceutical company, he reviewed the main work in 2020 from the aspects of epidemic prevention and control and resumption of production, safety and environmental protection management, product development and technological innovation, marketing management, standardizing production and operation behavior, talent recruitment and training, brand promotion of companies and products, and the work of the party and government work group, and analyzed the industry policy and development trend in 2021. He pointed out that the pharmaceutical industry will still have to face strict industry regulatory policies and severe market competition in 2021, and "recovery, innovation, integration and compliance" will be the key words of China's pharmaceutical economy in 2021. The pharmaceutical company will focus on the overall goal of "reducing costs, expanding the market, increasing speed, and creating benefits", and carry out various production and operation management work in an orderly manner. Jiang Xiaomeng, chairman of
Group Company and chairman of Pharmaceutical Company, attended the meeting. On behalf of the Group Company, he congratulated the advanced collectives and individuals who were commended, affirmed the work of Jianfeng Pharmaceutical in 2020, and put forward requirements for the work of Pharmaceutical Company in 2021. He requested that pharmaceutical companies should create three advantages and create new performance from three aspects: innovative research and development, preparation costs, and API characteristics; make breakthroughs in innovative marketing, management capabilities and thinking, and further refresh marketing capabilities and labor productivity. Reduce costs. At the same time, he hopes that all employees of the pharmaceutical industry will have a sense of urgency, mission and crisis, and complete various indicators of the pharmaceutical company through the efforts of all parties. At the
meeting, the pharmaceutical company awarded the advanced collectives and individuals in 2020. On behalf of the pharmaceutical company, Huang Jinlong signed a new year's economic target responsibility system with the heads of its subordinate enterprises.
This meeting was presided over by Jin Huazhong, Secretary of the Party Committee of Pharmaceutical Company, and summarized the contents of the meeting.
2On the 4th, Guizhou Huangping Jianfeng Cement Company held a summary commendation meeting to commend the advanced collectives and individuals in 2020 and convey the spirit of the group's annual business analysis meeting and summary commendation meeting. Huang Ping Jianfeng Manufacturing Department Yu Wang Yang, Purchasing Department Yang Changyuan and Marketing Department Long Liwei spoke at the meeting as advanced representatives.
2
On the 5th, at the summary commendation meeting held by daye peak cement company, Zhang Fengliang, deputy general manager of the group company and general manager of daye peak cement company, made a 2020 work report, summarizing the progress made by daye peak during the 13th Five-Year Plan period from the aspects of increasing per capita labor productivity year by year, continuous growth of employee income, increasingly standardized enterprise management, and effective technological transformation. He analyzed the challenges brought about by the changes in the external environment of the cement industry in 2021, as well as the shortcomings in the internal management of the enterprise, and required middle-level managers not only to learn from others and learn from others, but also to learn management knowledge and improve themselves. Management ability, always pay attention to the development of domestic and foreign industries, and know their own equipment and technical level; all employees should have a strong sense of responsibility and mission, have passion for work, transmit positive energy, do not care about it, base on their own work, earnestly safeguard the interests of the enterprise, work conscientiously, unite sincerely, and achieve the same progress and common development of enterprises and individuals. Themeeting also awarded honorary certificates to advanced individuals and collectives, and advanced representatives Ke Quanjun and Liu Lin made speeches.
2# On the afternoon of July 7, at the summary and commendation meeting of Jianfeng Health Technology Company, employees gathered together to sum up the past and talk about the future. The peak health management team presented awards to advanced collectives, outstanding employees and "1 1" direct purchase outstanding marketers. Yin Zhiwu, general manager of Jianfeng Health, said that in 2021, Jianfeng Health will focus on the business idea of developing health products (health food and ordinary food), supplemented by plant extracts and Chinese herbal pieces. It will make concerted efforts to create the fist products of health products business, focus on the investment promotion agency sector, and complement entrusted processing, group purchase and retail terminals. Organize production and operation in strict accordance with GMP requirements and food regulations; Strictly pay attention to safety and environmental protection work, strive to be a safe and environmentally friendly accident-free factory.
2 On the 8th, the cable company used the morning meeting platform to summarize and commend. Zhang Ci, general manager of the cable company, made an annual work report for 2020, summarizing the outstanding highlights and achievements of the marketing department, production department, technology department and comprehensive finance department, and arranging the specific work ideas and efforts for 2021. Yu Jianhong, general manager of
Group Company, attended the meeting and presented awards to advanced collectives and outstanding employees. He congratulated the advanced collectives and individuals, affirmed the achievements of the cable company in 2020, and put forward requirements for the work of the cable company in 2021. He hopes that all employees of the cable company will establish confidence and make persistent efforts to believe that they can cope with external difficulties and have the ability to enable the cable company to achieve better benefits; further strengthen management and improve the level of technology; further increase market acceptance capabilities and improve technology Level, expand customer coverage, and enhance the reputation of cable companies. (qi jianmei, ni yingzhen, pan yi, wang yuhua, xu ying, zhou guangliang, xu feng, huang yuan)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31